Pushing the boundaries of science

Scientists in Roche Pharma Research and Early Development are pushing boundaries to make medical breakthroughs for people and society. Here you can discover some of the areas where they are leading the field.

Advancing Novel Classes of Antibiotics

Roche’s commitment to creating and developing researching and developing new medicines to tackle drug resistance

Roche’s lifesaving legacy in antibiotic innovation

Finding new ways to kill bacteria is crucial against antimicrobial resistance. For Roche, it's been a 45-year legacy of innovative antibiotics and saving lives.

An immune upgrade for organoids

Engineering breakthrough for intestinal epithelial organoids with tissue-resident immune cells recapitulate drug-induced, immune-mediated toxicities.

Improving the patient journey

From diagnostics to therapeutics, Roche is innovating new options for people living with Alzheimer’s disease

Engineering models of the human gut

New “organoid-on-a-chip” system merges stem cell biology and innovation in engineering to better represent organs for research and development.

Doubling our vision

By combining a unique medical device with new medicines, Roche is turning breakthrough discoveries into groundbreaking inventions for patients with retinal disease

Redefining Parkinson’s disease

Redefining Parkinson's Disease: Science, technology, and passion converge to revolutionise the understanding and treatment of neurodegenerative diseases, offering new hope for patients and families.

Defining hallmarks of stem cells

A new review from Roche scientists describe stem cells’ unique and shared features, laying the foundation of what is known about them and mapping new approaches in drug discovery

New era of antibiotics potentially in sight after more than 50 years

By finding a new class of antibiotics, Roche’s scientists could contribute to reducing the globally growing number of deaths related to hospital-acquired bacterial infections

Series

The RNA Hub - An integrated multidisciplinary research community

Roche is shaking up the drug development process for new RNA-based medicines

Fighting inflammation in the eye

How a potential new molecule for retinal diseases could help close a gap of unmet medical need

An innovative hub for innovative medicines

Roche is shaking up the drug development process for new RNA-based medicines

From idea, to molecule, to medicine

The step-by-step evolution of a potential new approach to treating cancer.

Modeling the future

Roche launches the Institute of Human Biology to pioneer new approaches for drug discovery and development, leveraging human model systems such as organoids

Meet the antibody engineers

How teams across Roche are tweaking versatile immune tools to develop new treatments

Harnessing Immune Power Against Tumours

How Roche follows the science to continue improving on bold new therapeutic strategies.